Oxford Nanopore Technologies (LON:ONT) Given Outperform Rating at Royal Bank Of Canada

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “outperform” rating reissued by stock analysts at Royal Bank Of Canada in a note issued to investors on Tuesday,London Stock Exchange reports. They presently have a GBX 225 price target on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 74.42% from the company’s current price.

Oxford Nanopore Technologies Stock Down 0.7%

Shares of Oxford Nanopore Technologies stock opened at GBX 129 on Tuesday. The stock has a market capitalization of £1.25 billion, a P/E ratio of -8.54 and a beta of 0.87. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96. The stock has a 50 day moving average price of GBX 117.33 and a two-hundred day moving average price of GBX 129.61. Oxford Nanopore Technologies has a 12-month low of GBX 104 and a 12-month high of GBX 224.80.

Oxford Nanopore Technologies (LON:ONT) last announced its earnings results on Monday, March 2nd. The company reported GBX (15.10) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Nick Keher sold 22,993 shares of the company’s stock in a transaction that occurred on Tuesday, April 14th. The stock was sold at an average price of GBX 108, for a total transaction of £24,832.44. Insiders purchased 22,678 shares of company stock worth $2,563,129 in the last three months. 2.33% of the stock is owned by insiders.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.